Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-26 · accession 0001259780-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-27 | 2026-02-26 | INO | KIES PETER | CFO | F - Tax | $1.79 | -9,259 | 36.6K | -20% | -$16.6K |
| DM | 2026-02-27 | 2026-02-26 | INO | KIES PETER | CFO | M - OptEx | — | +15.6K | 35.3K | +80% | — |
| DM | 2026-02-27 | 2026-02-26 | INO | KIES PETER | CFO | M - OptEx | $0.00 | -15.6K | 21.3K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | F | D | 2,965 | $1.79 | 32,302 | D | — | — | (F2) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 2 | Common | Common Stock | 2026-02-26 | M | A | 10,634 | — | 42,936 | D | — | — | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Common | Common Stock | 2026-02-26 | M | A | 5,010 | — | 35,267 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Common | Common Stock | 2026-02-26 | F | D | 6,294 | $1.79 | 36,642 | D | — | — | (F4) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein. |
| 5 | Derivative | Restricted Stock Unit | 2026-02-26 | M | D | 5,010 | $0.00 | 5,009 | D | — · — to — | 5,010 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 6 | Derivative | Restricted Stock Unit | 2026-02-26 | M | D | 10,634 | $0.00 | 21,266 | D | — · — to — | 10,634 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |